feed,title,long_url,short_url
Benzinga,"Travere Therapeutics' Rare Kidney Disease Drug Disappoints In Phase 3 Study, Analyst Says Efficacy Trends Suggest Potential Path Forward",https://benzinga.com/analyst-ratings/analyst-color/23/05/32150212/travere-therapeutics-rare-kidney-disease-drug-disappoints-in-phase-3-study-analyst-,https://da.gd/QYz8t
